U.S. pharmaceutical concern Johnson & Johnson on
Tuesday reported a fall in third quarter net income to $3 billion, or $1.15 a share, down from $3.2 billion in the same
period last year.
The 7.3 percent decline was attributed to increased research and production costs.
Revenues rose to $17.1 billion, a rise of 6.5 percent over the same quarter last year. The stronger dollar hurt the value of foreign sales, which otherwise would have grown 10.8 percent over the same quarter last year, the company said.
Most Popular Stories
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Apple, HP, Intel May Take a Hit from Slowdown in Smartphone Sales Growth
- FDIC Files Lawsuit on Behalf of Banks Allegedly Hurt by Libor Scandal
- Elizabeth Vargas' Husband Marc Cohn Addresses Rumors
- Motley Crue's Nikki Sixx Marries Model Courtney Bingham
- Keurig Adds Peet's coffee, Alters Starbucks deal
- Chinese e-Commerce Giant Alibaba Gears for IPO in U.S.
- U.S. to Relinquish Gov't Control Over Internet
- Some California Cities Seeking Water Independence
- Will Missing Malaysian Jet Prompt Aviation System Change?